Skip to main content
. 2011 Dec 13;2012:658310. doi: 10.1155/2012/658310

Table 3.

Pregnancy outcomes following exposure to ACE/ARBs or other antihypertensives as compared to a healthy comparator group.

Characteristic ACE/ARB exposed (n = 139a) Other antihypertensives (n = 112b) Healthy nonexposed (n = 138) P value
Fetal outcome
 Livebirth
 Spontaneous abortion
 Elective abortion
 Fetal death
108 (77.7%)
25 (18.0%)
6 (4.3%)
0
105 (93.7%)
4 (8.9%)
0
3 (2.7%)
120 (88.2%)
16 (11.8%)
0
0
<0.001
Gestational age at birth (wks ± SD) 37.6 ± 3.1 37.8 ± 2.8 39.6 ± 1.6 <0.001
Delivery
 Vaginal
 Cesarean section
62/108 (57.4%)
46/108 (42.6%)
57/106 (53.8%)
49/106 (46.2%)
83/120 (69.1%)
37/120 (30.8%)
0.045
Preterm delivery
 No
 Yes
81/108 (75%)
27/108 (25%)
79/105 (75.2%)
26/105 (24.8%)
117/120 (97.5%)
3/120 (2.5%)
<0.001
Birth weight (grams ± SD) 3225 ± 862 3063 ± 839 3511 ± 471 <0.001
Sex
 Male 59 (54.6%) 49 (46.6%) 57 (47.5%) 0.43
Fetal malformations
 Yes 2/108 (1.8%) 2/105 (1.9%) 2/120 (1.6%) 0.99

aIncluding 1 twin pregnancy.

bIncluding 2 twin pregnancies.

Fetal malformations are reported as a proportion of liveborn (in the ACE/ARB group-1 choanal atresia and 1 hypospadias, in the other antihypertensives group-1 unspecified heart murmur and 1 undescended testicle, in the health unexposed group-1 Down's syndrome and 1 inguinal hernia).